Design and synthesis of thieno[2,3-d]pyrimidine derivatives and their biological evaluation as Antitumor and anti-HIV agents / Ramy Sayed Aboelella Ahmed ; Supervised Fatma Abdelfattah Ragab , Sahar Mahmoud Abouseri , Diaa Abdelsamei
Material type: TextLanguage: English Publication details: Cairo : Ramy Sayed Aboelella Ahmed , 2016Description: 127 P. : charts , facsimiles ; 25cmOther title:- HIVتصميم و تشييد بعض مشتقات الثيينو (3,2-د)بيريميدين و تقييم فاعليتها البيولوجية كمضادات للأورام فيروس [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.05.M.Sc.2016.Ra.D (Browse shelf(Opens below)) | Not for loan | 01010110070931000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.05.M.Sc.2016.Ra.D (Browse shelf(Opens below)) | 70931.CD | Not for loan | 01020110070931000 |
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry
In a search for new cytotoxic agents with improved anticancer profile, some new thienopyrimidine and thienotriazolopyrimidine derivatives were synthesized. All the synthesized compounds are tested for their in-vitro cytotoxicity against human breast cancer cell line (MCF-7) in which tyrosine kinases are highly expressed. All target compounds are then subjected for further evaluation against receptor tyrosine kinase enzymes; namely, epidermal growth factor receptor (EGFR), (ErbB-2) and vascular endothelial growth factor receptor-2 (VEGFR-2).Compounds in series I were designed to be nonnucleoside reverse transcriptase inhibitors (NNRTIs). Compounds Va-f were assayed for their inhibitory activity against HIV-1 (IIIB strain) and HIV-2 (ROD strain) using nevirapine as a reference inhibitor. They were found to be moderately active against reverse transcriptase
Issued also as CD
There are no comments on this title.